People · Operator
Named in public records as an officer, director or promoter · active 2010–2024 · Biotechnology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Seventh Sense Biosystems, Inc. | — | Biotechnology | Series B | $62.9M | $732.6M | 2010 |
| S2N Health Inc. | — | Healthtech | Series A | $4.5M | $22.8M | 2023 |
AMY SIEGEL at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside AMY SIEGEL on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Langer | 1 | 36 |
| Andrew Schwab | 1 | 16 |
| Alan Crane | 1 | 9 |
| Harry Wilcox | 1 | 6 |
| Doug Cole | 1 | 6 |
| NEIL EXTER | 1 | 5 |
| Timothy Richards | 1 | 4 |
| PETER HUTT | 1 | 4 |
| HOWARD WEISMAN | 1 | 3 |
| R. ROX ANDERSON | 1 | 3 |
| Stuart Blitz | 1 | 2 |
| Martha Shadan | 1 | 2 |
| Milan Kofol | 1 | 2 |
| DOUG LEVINSON | 1 | 2 |
| HOWARD BERNSTEIN | 1 | 2 |
| MILAN ROX KOFOL | 1 | 1 |
| DONALD ROX HARDISON | 1 | 1 |
| ALAN ROX CRANE | 1 | 1 |
| DOUG ROX COLE | 1 | 1 |
| DON CHICKERING | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.